A Randomized Trial to Increase Access to Breast Cancer Screening by Invitation Language Among Immigrants in Norway
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 11,355
- 试验地点
- 2
- 主要终点
- Screening attendance
研究概览
简要总结
The investigators aim to test whether inviting immigrants to breast cancer screening with a letter in their mother tongue in addition to the standard letter in Norwegian changes screening uptake in these immigrant groups, compared with a comparable group who receive the invitation in Norwegian only,
详细描述
Women in selected immigrant groups according to birth country will be invited to screening and randomized in a 1:1 ratio to receive the screening invitation and information material 1) in the major official native language in the country the invitee is born in addition to Norwegian (intervention group), or 2) only Norwegian (control). The 13 selected countries of origin are Poland, the Philippines, Pakistan, Somalia and Arabic speaking countries (Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia). The five intervention languages will thus be Polish, English, Urdu, Somali and Arabic.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Participant)
盲法说明
The screening invitees randomized to the control group are not informed about this study. They receive "care as usual", the screening invitation letter in Norwegian language.
入排标准
- 年龄范围
- 48 Years 至 73 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Invited to screening program during the study recruitment period (January 2021-June 2022)
- •The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia
排除标准
- •Not reached with the screening invitation letter because of wrong address or similar
结局指标
主要结局
Screening attendance
时间窗: 0-6 months after sent screening invitation letter
Attendance in breast cancer screening programme (yes/no)
次要结局
未报告次要终点
研究者
Paula Berstad
Researcher
Oslo University Hospital